Publication | Closed Access

Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer

Geriatric OncologyGeriatricsMedicineCancer ManagementClinical TrialsPathologyColorectal CancerGeriatric AnalysisProdige 20Cancer TreatmentOncologyRadiation OncologyOlder PatientsHealth Sciences